Instillido (Lidocaine Hydrochloride)

Lidocaine works by reversibly binding to voltage‑gated sodium channels on nerve cells. This blocks sodium influx during depolarisation, preventing the generation and propagation of nerve impulses, which results in a temporary loss of sensation in the treated area.

The appropriate dose of Instillido is determined by the prescribing clinician based on the specific procedure, patient characteristics, and clinical setting. Healthcare professionals calculate the volume needed to achieve effective urethral anesthesia while minimizing systemic exposure.

Safety data for Instillido in pregnancy or lactation are limited. The product’s pregnancy category is listed as unknown, so clinicians should weigh potential benefits against risks and consider alternative options when treating pregnant or nursing patients.

To order Instillido, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Instillido delivers lidocaine, a widely used amide‑type local anesthetic known for rapid onset and moderate duration. Compared with ester‑type agents such as benzocaine, lidocaine generally offers a more predictable pharmacokinetic profile and lower risk of allergic reactions, making it a preferred choice for urethral procedures.

Instillido should be stored at room temperature, below 25 °C, in its original container. Protect the solution from moisture, direct sunlight, and extreme temperature fluctuations. Ensure the vial is sealed until use and discard any product that appears discoloured or contaminated.

Instillido is administered by instilling the prescribed volume of the sterile solution directly into the urethra using a suitable applicator or catheter. The procedure is performed by trained healthcare personnel, and the onset of anesthesia typically occurs within minutes.

The most serious risks include severe allergic reactions such as anaphylaxis, cardiac arrhythmias or conduction disturbances, and central nervous system toxicity leading to seizures. Prompt recognition and management of these events are essential, and patients should be monitored during and after administration.

Instillido should be avoided in individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics. Patients with significant cardiac conduction abnormalities, uncontrolled epilepsy, or those receiving interacting medications listed under major interactions should also be evaluated carefully before use.